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Abstract. 
 
The regulation of sphingolipid transport to 
the bile canalicular apical membrane in the well dif-
ferentiated HepG2 hepatoma cells was studied. By 
employing fluorescent lipid analogs, trafficking in a 
transcytosis-dependent pathway and a transcytosis-
independent (‘direct’) route between the 
 
trans
 
-Golgi 
network and the apical membrane were examined. The 
two lipid transport routes were shown to operate inde-
pendently, and both were regulated by kinase activity. 
The kinase inhibitor staurosporine inhibited the direct 
lipid transport route but slightly stimulated the transcy-
tosis-dependent route. The protein kinase C (PKC) ac-
tivator phorbol-12 myristate-13 acetate (PMA) inhib-
ited apical lipid transport via both transport routes, 
while a specific inhibitor of this kinase stimulated apical 
lipid transport. Activation of protein kinase A (PKA) 
had opposing effects, in that a stimulation of apical lipid 
transport via both transport routes was seen. Interest-
ingly, the regulatory effects of either kinase activity in 
sphingolipid transport correlated with changes in cell 
polarity. Stimulation of PKC activity resulted in a dis-
appearance of the bile canalicular structures, as evi-
denced by the redistribution of several apical markers 
upon PMA treatment, which was accompanied by an 
inhibition of apical sphingolipid transport. By contrast, 
activation of PKA resulted in an increase in the number 
and size of bile canaliculi and a concomitant enhance-
ment of apical sphingolipid transport. Taken together, 
our data indicate that apical membrane-directed sphin-
golipid transport in HepG2 cells is regulated by kinases, 
which could play a role in the biogenesis of the apical 
plasma membrane domain.
 
P
 
olarized 
 
cells have different membrane domains,
i.e., an apical and a basolateral domain, each dis-
playing a specific protein and lipid composition.
The polarization is fundamental to the specialized func-
tions of cells and newly synthesized lipid and proteins
must therefore be delivered to the correct domain to
maintain this cell polarity.
There are several mechanisms that cells can use for this
purpose. In the direct pathway, newly synthesized mem-
brane proteins are transported from the endoplasmic re-
ticulum via the Golgi apparatus to the 
 
trans
 
-Golgi network
(TGN). After arrival in the TGN, proteins are packaged
into distinct transport vesicles destined for the apical or
basolateral domain. Alternatively, cells can use an indirect
pathway for protein sorting, in which proteins are first
transported from the TGN to the basolateral surface. They
are then endocytosed and are subsequently either recycled
to the basolateral surface, or are sorted from the basolat-
eral proteins and delivered to the apical surface by trans-
cytosis. Studies in several polarized cell types showed that
the importance of each pathway depends on the cell type.
MDCK epithelial cells use predominantly the direct path-
way, while Caco-2 cells make use of both pathways (35).
Hepatocytes are polarized cells as well, with the apical
or canalicular domain facing the bile canaliculus and the
basolateral or sinusoidal domain facing the blood. In this
cell type only the indirect pathway seems to be operational
for the targeting of apical membrane proteins (5, 27, 38),
although some evidence for direct protein transport be-
tween the Golgi and the apical plasma membrane also ex-
ists (1, 37).
Like proteins, lipids also have a polarized distribution.
Using fluorescently labeled sphingolipid analogs, it has
been demonstrated that in MDCK and Caco-2 cells, newly
synthesized sphingolipids use a direct pathway and are
sorted before they reach the plasma membrane, leading to
an enrichment of glycosphingolipids in the outer leaflet of
the apical plasma membrane (43, 46). No sorting of sphin-
golipids was observed during epithelial transcytosis (44).
In hepatocytes, in which the direct route for sorting of api-
cal membrane proteins seems to be absent, it has been sug-
gested that lipids, destined for secretion into bile, are sorted
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in specific ER-derived vesicles that are transported via the
Golgi to the canalicular membrane (34). For the bile salt
lithocholate, a canalicular directed route that involved the
Golgi apparatus has also been suggested (49).
Recently, molecular factors involved in the regulation of
(polarized) membrane transport were identified. It has
been shown that activation of the Gs class of heterotri-
meric G proteins stimulates both transcytosis (8, 20) and
transport from the TGN to the apical surface (31). The
classical downstream target of Gs is adenylate cyclase. It
has been demonstrated that an increase of intracellular
cAMP and a subsequent activation of the cAMP-depen-
dent protein kinase A (PKA),
 
1
 
 can stimulate transcytosis
as well as TGN-to-apical transport (20, 32). Also for other
kinases a role in apical transport was suggested. Activation
of protein kinase C (PKC) by phorbol esters stimulates the
apical transport of influenza hemagglutinin from TGN to
the apical surface (32). Moreover, PKC was reported to
stimulate basolateral-to-apical transcytosis (13).
In this study we have investigated the transport path-
ways by which the transfer of apically directed lipid is ac-
complished and whether, in analogy to protein transport,
such transport pathways are regulated by kinase activity.
Previously, we have identified a transcytosis-dependent
and a transcytosis-independent (‘direct’) lipid transport
route, using fluorescent lipid analogs (50). In the current
work we employed modulators of PKC and PKA activity
to investigate the regulation of these membrane transport
pathways. The results presented here show opposing ef-
fects of both kinases on apical sphingolipid transport.
Moreover, reduced apical sphingolipid delivery, induced
by the PKC activator PMA, correlated with the loss of the
apical plasma membrane domain, whereas an elevation of
intracellular cAMP induced a PKA-mediated enlargement
of the apical domain. We therefore propose that both ki-
nases have a function in the formation and maintenance of
the apical membrane domain in HepG2 cells.
 
Materials and Methods
 
Materials
 
DME medium was obtained from GIBCO BRL Life Technologies (Paisley,
Scotland); FCS was purchased from BioWhittaker (Verviers, Belgium).
 
d
 
-sphingosine, 1
 
b
 
-
 
d
 
-glucosylsphingosine, and sphingosylphosphorylcho-
line were from Matreya (Pleasent Gap, PA), and 6-[
 
N
 
-(7-nitrobenz-2-oxa-
1,3 diazol-4-yl)amino]hexanoic acid (C
 
6
 
-NBD) was from Molecular Probes,
Inc. (Eugene, OR). Forskolin and H89 (
 
N
 
-[2-(p-bromocinnamylamino)
ethyl]-5-iso-quinolinesulfonamine) were from Calbiochem-Novabiochem
Corporation (La Jolla, CA), and dibutyrylcAMP (dBcAMP) and bisin-
dolylmaleimide (BIM) were purchased from Boehringer Mannheim
GmbH (Mannheim, Germany). IBMX (3-isobutyl-1-methylxantine), TRITC-
labeled phalloidin, staurosporine, phorbol-12-myristate-13-acetate (PMA)
and Hoechst 33258 (bisbenzimide) were supplied by Sigma Chemical Co.
(St. Louis, MO). Paraformaldehyde, HPTLC plates and organic solvents
were from Merck (Darmstadt, Germany). The monoclonal antibodies
against hepatic bile canaliculi (MAB 442) and villin were from Chemicon
(Temecula, CA). The 
 
P
 
-glycoprotein-specific mouse monoclonal antibody
C219 was kindly provided by Han Roelofsen (University of Groningen,
The Netherlands). FITC-conjugated antibodies were from Nordic Immu-
nology Laboratories (Tilburg, The Netherlands).
 
Cell Culture
 
HepG2 cells were grown in DME medium containing 4.5 g/liter glucose,
supplemented with 10% FCS, 2 mM 
 
l
 
-glutamine, penicillin (100 IU/ml),
and streptomycin (100 
 
m
 
g/ml), at 37
 
8
 
C in a humidified atmosphere of 5%
CO
 
2
 
 in air. Experiments were performed 3 d after cell plating. We and
others (14) found that at this time after plating, the ratio between bile
canalicular structures and cells is maximal (see Table II). Cells were
grown on 94-mm culture dishes for biochemical experiments and on glass
coverslips for microscopy.
 
Synthesis of C
 
6
 
-NBD–sphingolipids
 
C
 
6
 
-NBD–ceramide (C
 
6
 
-NBD–Cer), C
 
6
 
-NBD–sphingomyelin (C
 
6
 
-NBD–SM),
and C
 
6
 
-NBD–glucosylceramide (C
 
6
 
-NBD–GlcCer) were synthesized from
C
 
6
 
-NBD and 
 
d
 
-sphingosine, 1
 
b
 
-
 
d
 
-glucosylsphingosine and sphingosylphos-
phorylcholine, respectively (3, 23).
 
Cell Labeling and Lipid Transport Assays
 
Insertion and Back Exchange of Fluorescent Lipids.  
 
Cells were washed three
times with cold PBS. C
 
6
 
-NBD–lipids were added to cold HBSS by means
of ethanolic injection. Lipids from a stock solution in chloroform/metha-
nol (2:1 vol/vol) were dried under nitrogen and solubilized in absolute eth-
anol. The ethanolic solution was subsequently injected into HBSS under
vigorous vortexing. The final concentration of ethanol did not exceed
0.5% (vol/vol).
When required, C
 
6
 
-NBD–lipids present in the outer leaflet of the
plasma membrane were removed by a back exchange procedure. To this
end the cells were incubated for 30 min at 4
 
8
 
C with 5% BSA in HBSS, fol-
lowed by washing with cold HBSS. This procedure was repeated once.
 
Transcytosis of Lipids.  
 
Transcytosis of sphingolipid was determined by
labeling the plasma membrane of HepG2 cells with C
 
6
 
-NBD–GlcCer or -SM
for 30 min at 4
 
8
 
C. The cells were then washed and subsequently incubated
at 37
 
8
 
C for 15 min to allow internalization and transcytosis to the bile
canalicular domain. The cells were then cooled to 4
 
8
 
C, and the lipid re-
maining in the outer leaflet of the plasma membrane was removed by a
back exchange at 4
 
8
 
C. The apical labeling of the bile canalicular structures
was determined semi-quantitatively by assessing the percentage of bile
canaliculi that was NBD positive. The bile canaliculi, which are easily vi-
sualized under phase-contrast by their microvillar appearance, were classi-
fied as NBD positive or negative under epifluoresence illumination. In
control cells, 
 
z
 
70% of the total population of bile canaliculi was NBD
positive after a 15-min incubation period at 37
 
8
 
C. Cells that were incu-
bated with NBD lipids at 4
 
8
 
C only showed a background labeling of bile
canaliculi of 
 
z
 
10% of the total population.
 
Apical Delivery of De Novo Synthesized Lipids.  
 
Cells were plated on
coverslips and labeled with C
 
6
 
-NBD–Cer for 60 min at 4
 
8
 
C. To allow for
synthesis of C
 
6
 
-NBD–GlcCer or -SM and their subsequent transport, an
incubation was carried out at 37
 
8
 
C for 60 min in HBSS with or without 5%
BSA. Cells that were incubated at 37
 
8
 
C in the absence of back-exchange
medium (HBSS containing 5% BSA) were subjected to a back exchange
afterwards, and the apical delivery of sphingolipids was determined as
indicated above. In control cells, 
 
z
 
50% of the total population of bile
canaliculi was NBD positive after a 60-min incubation at 37
 
8
 
C. In cells
that had been incubated at 4
 
8
 
C only, no NBD-positive bile canaliculi were
observed (not shown).
 
Metabolism of C
 
6
 
-NBD–Cer and Basolateral Delivery of De Novo Synthe-
sized Sphingolipids.  
 
Cells were plated in 94-mm culture dishes and labeled
with C
 
6
 
-NBD–Cer for 60 min at 4
 
8
 
C. The cells were then incubated for
60 min at 37
 
8
 
C in HBSS containing 5% BSA. Subsequently they were
washed and scraped from the culture dish. Lipids from the incubation me-
dium and cells were extracted and quantified as described below.
 
Total Endocytic Uptake of Sphingolipids.  
 
The total endocytic uptake of
sphingolipids was determined by labeling cells with C
 
6
 
-NBD–GlcCer or -SM
for 30 min at 4
 
8
 
C. The cells were then washed and incubated at 37
 
8
 
C. At
the end of the incubation the cells were cooled to 4
 
8
 
C, and the lipid re-
maining in the outer leaflet of the plasma membrane was removed by
back exchange at 4
 
8
 
C. After washing, the cells were scraped from the cul-
ture dish. Lipids from the back-exchange medium and the cells were ex-
tracted and quantified. In the time span of our experiments (15 min at
37
 
8
 
C) no degradation of C
 
6
 
-NBD–GlcCer or -SM occurred, as revealed by
thin layer chromatography.
 
1. 
 
Abbreviations used in this paper
 
: BIM, bisindolylmaleimide; PKA, pro-
tein kinase A; PKC, protein kinase C; PMA, phorbol 12-myristate 13-ace-
tate; VAC, vacuolar apical compartment. 
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Lipid Extraction and Quantification.  
 
Lipids from cells and back-exchange
media were extracted according to the method of Bligh and Dyer (7). NBD
lipids were separated by thin layer chromatography and quantified fluoro-
metrically as described previously (24).
 
Immunofluorescence and Other Staining Procedures 
 
To stain F-actin, cells were washed with PBS and fixed for 10 s at 
 
2
 
20
 
8
 
C in
ethanol. F-Actin was then stained using 100 ng/ml TRITC-labeled phalloi-
din in PBS for 30 min at room temperature. To determine the ratio of bile
canaliculi per number of cells, cells were fixed with ethanol and dou-
blestained with 5 ng/ml of the nuclear stain Hoechst 33258 and 100 ng/ml
TRITC–phalloidin, for 30 min in PBS at room temperature. For staining
of the bile canalicular specific antigen with MAB442, cells were fixed with
3% paraformaldehyde in PBS for 30 min and permeabilized with 0.1%
Triton X-100 in PBS for 10 min. Cells, stained for villin, were fixed and
permeabilized for 5 min at 
 
2
 
20
 
8
 
C in acetone. Cells were then washed in
PBS, incubated for 30 min in PBS containing 2.5% FCS (PBS/FCS) to
block nonspecific binding sites, and subsequently incubated with primary
mouse monoclonal antibody, diluted in PBS/FCS (anti-villin 1:50, MAB
442 1:25). For staining 
 
P
 
-glycoprotein, cells were fixed for 5 min at 
 
2
 
20
 
8
 
C
in acetone. The cells were incubated overnight with the 
 
P
 
-glycoprotein–
specific mouse monoclonal antibody C219 at 4
 
8
 
C. After several washings,
the primary antibodies were revealed with FITC-conjugated goat anti–
mouse antibodies. Before microscopic examination, the cells were embed-
ded in glycerol containing 2.5% 1, 4-diazobicyclo[2.2.2]octane to prevent
bleaching.
 
Microscopy
 
Cells were examined using an epifluorescence microscope (Provis AX70;
Olympus Corp., New Hyde Park, NY). Photographs were taken using Ill-
ford HP-5 plus film.
 
Gel Electrophoresis and Western Blotting
 
Cells were treated with 100 nM PMA, 500 nM BIM, or both, for 1 or 4 h.
Cells were then washed in PBS and scraped from the culture dish. The
cells were spun down, solubilized in SDS sample buffer, and boiled for 5
min. Protein was determined according to Peterson’s modification of
Lowry et al. (30). Equal amounts of protein (20 
 
m
 
g) were separated on a
10% acrylamide gel using the system of Laemmli (26). Proteins were
transferred to Immobilon-P PVDF membrane (Millipore Corporation,
Bedford, MA) by Western blotting using the method of Towbin et al. (42).
Membranes were rinsed with PBS and incubated for 2 h with 10% nonfat
dry milk in PBS to reduce nonspecific binding. The membranes were
washed in PBS containing 0.3% Tween 20 (PBS/Tween) and incubated
overnight at room temperature with primary antibody in PBS/Tween con-
taining 1% nonfat dry milk. The membranes were washed three times with
PBS/Tween and were subsequently incubated with alkaline phosphatase-
conjugated sheep anti–mouse conjugated IgG antibodies. The membranes
were washed three times in PBS/Tween, and alkaline phosphatase was vi-
sualized using 
 
p
 
-nitroblue tetrazolium and 5-bromo-4-chloro-3-idolyl
phosphate.
 
Results
 
Sphingolipids Are Transported to Apical Membranes 
Via a Direct Route and Via Transcytosis
 
Previous work showed (50) that well differentiated human
hepatoma HepG2 cells contain a bile canalicular or apical
membrane domain to which fluorescent lipid analogs are
targeted. Apical lipid transport occurs via both basolateral
to apical transcytosis and a transcytosis-independent route,
which involves transport of Golgi-derived, de novo synthe-
sized sphingolipids. Throughout this work we refer to the
latter pathway as the ‘direct’ transport route since it does
not involve flow of newly synthesized sphingolipids via the
plasma membrane (see below), before their delivery to the
apical plasma membrane. Neither transport route is specific
for the HepG2 cell line, but were also demonstrated to op-
erate in isolated human hepatocyte couplets (50). The
present work was undertaken to study the mechanisms
that may be involved in the regulation of transcytotic and
direct apical lipid transport. Transport of de novo synthe-
sized sphingolipid from the Golgi apparatus to the apical
domain was studied by monitoring the flow of fluorescent
C
 
6
 
-NBD–SM and -GlcCer, synthesized from the exoge-
nously added short-chain sphingolipid precursor, C
 
6
 
-
NBD–Cer (22). After accumulation in the Golgi, the lipid
products are transported to the bile canaliculus (50) and to
the basolateral plasma membrane. Lipid arriving at the ba-
solateral plasma membrane was extracted from the outer
leaflet by the presence of BSA in the incubation medium,
thereby preventing lipid from re-entering the cells by
means of endocytosis. It should be emphasized that label-
ing of the bile canalicular membrane domain was accom-
plished by vesicular transport of C
 
6
 
-NBD–SM and -GlcCer,
rather than by labeling as a result of monomeric exchange
of C
 
6
 
-NBD–Cer, which primarily resides in the Golgi lumen
(see 29). Thus, in the presence of an inhibitor of sphin-
golipid biosynthesis, 
 
d
 
,
 
l
 
-threo-1-phenyl-2-decanoyl amino-3-
morpholino-1-propanol (PDMP), labeling of the bile cana-
liculi is not observed, in spite of the excess of C
 
6
 
-NBD–Cer,
present under these conditions (not shown). Neither dis-
plays the significant labeling of the apical domain seen
when lipid transport exiting from the Golgi is inhibited in
the presence of 10 
 
m
 
M monensin (45). By exogenous addi-
tion of C
 
6
 
-NBD–SM and -GlcCer, basolateral endocytosis
and subsequent transcytotic delivery of sphingolipids to
the apical domain was studied (the ‘indirect pathway’) and
compared with the transport of the de novo formed sphin-
golipids.
In Fig. 1, typical labeling of bile canaliculi as accom-
plished via either pathway is shown. Note the remarkable,
pathway-dependent differences in labeling pattern. Cells
labeled with C
 
6
 
-NBD–SM (Fig. 1 
 
a
 
) showed brightly la-
beled bile canaliculi and, in addition, a punctate vesicular
staining. The latter presumably originates from the pres-
ence of the lipid analog in endosomal compartments, in
analogy with other studies (24, 25). When cells were la-
beled with C
 
6
 
-NBD–GlcCer, a similar labeling pattern was
observed (data not shown). Interestingly, the vesicular la-
beling that we observed when NBD sphingolipids were
added exogenously to the cells was conspicuously absent
when de novo synthesized sphingolipids were transported
to the bile canaliculi. When the cells were labeled with C
 
6
 
-
NBD–Cer and subsequently incubated at 37
 
8
 
C to allow
metabolism and transport of the sphingolipid products,
only the Golgi apparatus and the bile canaliculi were
prominently labeled. Both in the absence (Fig. 1 
 
b
 
) and
presence (not shown) of BSA in the incubation medium,
an identical labeling pattern was obtained, implying that
apical transport of Golgi-derived sphingolipids did not in-
volve prior delivery to the basolateral plasma membrane,
followed by endocytic uptake.
 
Staurosporine Stimulates Transcytosis of
Sphingolipids but Inhibits Apical Delivery of De Novo 
Synthesized Sphingolipid
 
Studies in polarized epithelial cells showed that kinase ac- 
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tivity regulates protein transport from the TGN to the api-
cal surface, while only minor effects on the basolateral de-
livery were found (10, 20, 32). To examine whether kinases
play a role in the regulation of apical lipid transport, the
effect of staurosporine, a potent kinase inhibitor, was de-
termined. As shown in Fig. 2, in HepG2 cells, staurospo-
rine inhibited direct sphingolipid transport to the bile canalic-
uli and had a small, but reproducible, stimulating effect on
the transcytosis of basolaterally applied C
 
6
 
-NBD–GlcCer
or -SM. The transport of de novo synthesized lipids was also
inhibited by staurosporine when BSA was not present in
incubation medium, confirming a transport pathway be-
tween Golgi and the apical membrane that is essentially
endocytosis independent, and emphasizing that both trans-
port routes are regulated differentially by kinase activity.
Labeling of the bile canaliculi depends on the conver-
sion of C
 
6
 
-NBD–Cer into its products C
 
6
 
-NBD–SM and
-GlcCer (50), which implies a requirement of sphingolipid
synthesis for the occurence of apical transport of these flu-
orescent analogs (see also above). As a control, we there-
fore examined whether staurosporine inhibits the metabo-
lism of C
 
6
 
-NBD–Cer, which would also result in a reduced
sphingolipid transport to the apical membrane. The me-
tabolism of C
 
6
 
-NBD–Cer was analyzed under the same
conditions as those used in the apical transport assay. Un-
expectedly, staurosporine stimulates the conversion of C
 
6
 
-
NBD–Cer to -SM and -GlcCer (Table I). However, the
relative transport to the basolateral plasma membrane, as
determined by the fraction of total lipid that can be back
exchanged, is not influenced by staurosporine. Therefore,
the absolute amounts of basolaterally transported C
 
6
 
-
NBD–GlcCer and -SM are higher in staurosporine-treated
cells. Nevertheless, the results are entirely consistent with
the notion that staurosporine inhibits the direct, TGN-
to-apical membrane transport pathway.
The staurosporine-induced enhancement of basolateral-
to-apical transcytotic transport of C
 
6
 
-NBD–GlcCer and -SM
could have relied upon an increase of total cellular uptake.
The total uptake was determined after labeling cells with
sphingolipid analogs for 30 min at 4
 
8
 
C. After washing, cells
were incubated at 37
 
8
 
C for several time intervals, cooled,
and back exchanged to remove lipid remaining in the ba-
solateral plasma membrane. The intracellular lipid pool
was subsequently quantified as described in Materials and
Methods. No enhancement of the intracellular pools could
be detected upon treatment by staurosporine over the
time span of the transcytosis studies (Fig. 3). The in-
creased labeling of the apical membrane by transcytosis
therefore does not correlate with a stimulation of endocy-
tosis of the sphingolipids by staurosporine. Rather, the
data would support an enhanced efficiency of transcytotic
trafficking from an internal pool.
Figure 1. Transfer of fluores-
cent lipid analog to bile
canaliculi via the direct path-
way and via transcytosis.
HepG2 cells were labeled at
48C with 3 mM C6-NBD–Cer
to reveal the direct pathway
and C6-NBD–SM to visualize
the transcytosis-dependent
pathway, as described in Ma-
terials and Methods. Cells la-
beled with C6-NBD–SM
were incubated at 378C for 15
min to allow endocytic up-
take of the lipid. To remove
C6-NBD–SM remaining in
the basolateral plasma mem-
brane, the cells were back ex-
changed after the 378C incu-
bation. Cells labeled with C6-
NBD–Cer were incubated at
378C for 60 min to allow syn-
thesis and subsequent trans-
port of C6-NBD–lipid prod-
ucts in the absence of back
exchange medium. After the
378C incubation, the cells
were back exchanged. (a)
Cells labeled with C6-NBD–
SM display a bright labeling
of the bile canaliculus (ar-
rowhead) and an additional,
vesicular staining pattern.
(c) Cells that were labeled
with C6-NBD–Cer show an accumulation of NBD fluorescence, typical for localization at the Golgi apparatus and in the bile canalicu-
lus (arrowhead). Note the absence of a vesicular staining pattern in cells that were labeled with C6-NBD–SM (a). (b and d are phase
contrast images corresponding to a and c, respectively.) Bars, 10 mm.Zegers and Hoekstra PKC and PKA Regulate Apical Sphingolipid Transport 311
Apical Sphingolipid Transport Is Inhibited by Protein 
Kinase C Activity
Since staurosporine is a nonspecific inhibitor of several ki-
nases (36), a more detailed analysis of the kinases involved
in the regulation of apical sphingolipid transport was re-
quired. As shown in Fig. 4, the phorbol ester phorbol 12-
myristate 13-acetate (PMA), a compound that can substi-
tute for the physiological activator of PKC, diacylglycerol,
inhibits the apical transport of sphingolipids. In fact, both
the direct pathway of de novo synthesized C6-NBD–GlcCer
and -SM (Fig. 4 A), and transcytosis of basolaterally ap-
plied C6-NBD–GlcCer and -SM (Fig. 4 B) are inhibited. In
case of transport of newly synthesized sphingolipid ana-
logs from the Golgi to the apical membrane, the direct
pathway, an inhibition of z20% was seen at concentra-
tions as low as 5 nM. When raising the concentration to
20 nM, an inhibition of z30% was obtained (Fig. 4 A).
The inhibitory effects of PMA were not caused by an al-
teration of the metabolism of C6-NBD–Cer (see above).
Thus, 20 nM PMA affected neither the synthesis nor baso-
lateral transport of de novo synthesized C6-NBD–GlcCer
and -SM (data not shown). Furthermore, the inhibitory ef-
fect of PMA on sphingolipid transcytosis did not correlate
with an inhibition of the total cellular internalization of
lipids in treated cells. In fact, PMA slightly stimulated the
internalization of C6-NBD–SM but did not affect -GlcCer
internalization (see Fig. 11). Importantly, in both control
and PMA-treated cells, no significant degradation (,5%)
of NBD-labeled sphingolipid occurred over the time inter-
val of these experiments.
To obtain further support for the specific involvement
of PKC activity in regulating sphingolipid transport, we re-
peated the sphingolipid transport experiments in the pres-
ence of a specific inhibitor of PKC, bisindolylmaleimide
(BIM). The cells were preincubated with BIM before la-
beling with sphingolipid, while during cell labeling and all
subsequent incubations, both BIM and PMA were kept
present. As shown in Fig. 4, the inhibitory effect of PMA
on direct and transcytotic sphingolipid transport could be
overcome upon addition of BIM. Consistent with this bal-
anced effect of PMA (PKC activator) and BIM (PKC in-
hibitor) was the observation that treatment with BIM
alone stimulated apical sphingolipid delivery. This stimu-
lating effect of BIM was seen to occur in both transport
routes (Fig. 4). In control experiments, analogous to those
described above (Table I), it could be excluded that BIM
affected de novo synthesis and basolateral transport of C6-
NBD–GlcCer and -SM (data not shown).
Protein Kinase C Induces Depolarization of
HepG2 Cells
The data presented above show that, in the concentration
range of 5–20 nM, PMA inhibits sphingolipid transport to
the apical domain in HepG2 cells. When raising the con-
ments 6SEM. A shows the effect of staurosporine (SSP) on the
direct pathway in cells incubated for 60 min in the presence of back-
exchange medium, or 30 and 60 min in the absence of back-
exchange medium. B shows the effect of staurosporine on the
transcytosis of C6-NBD–GlcCer (white bars) and -SM (black bars).
Figure 2. Effect of staurosporine on apical lipid transport.
HepG2 cells were preincubated with 100 nM staurosporine in
HBSS at 378C for 30 min. Cells were then cooled and, in the pres-
ence of staurosporine, labeled and incubated with 3 mM C6-
NBD–Cer for determining lipid transport in the direct pathway
(A) and 3 mM C6-NBD–SM or -GlcCer for that in the transcyto-
sis-dependent pathway (B). Cells that were labeled with C6-
NBD–Cer were incubated at 378C both in the absence and pres-
ence of back-exchange medium. Apical transport of lipids was
determined by assessing the percentage of labeled bile canaliculi
as described in Materials and Methods. In each experiment a
minimum of 50 bile canalicular structures was counted. Each col-
umn represents the mean of three to five independent experi-The Journal of Cell Biology, Volume 138, 1997 312
centration of PMA to 100 nM, fluorescently labeled bile
canaliculi were no longer detectable. Indeed, above con-
centrations of 100 nM and up to 2 mM, bile canalicular
structures, readily identified by their microvillar appear-
ance, as revealed by phase-contrast microscopy, could no
longer be observed. In HepG2 cells, bile canaliculus for-
mation is accompanied and correlated with the accumula-
tion of actin filaments and the microvilli-associated protein
villin at the bile canalicular membrane (40). To investigate,
therefore, the seemingly inhibitory effect of PKC activity
on the biogenesis or maintenance of the canalicular do-
main, the intracellular organization of actin filaments and
villin was examined in control and PMA-treated cells, us-
ing TRITC-labeled phalloidin to detect actin and a mono-
clonal antibody against villin. As shown in Figs. 5 and 6, in
control cells an intensive staining of actin around the bile
canalicular structures (Fig. 6 a) and a specific staining of
villin of the bile canalicular microvilli is observed (Fig. 5).
MAB442, an antibody specific for the bile canalicular
membrane in human hepatocytes, was found to have a bile
canalicular localization in HepG2 cells as well (Fig. 7 a).
Remarkably, after a 60-min treatment with 100 nM PMA,
actin staining around bile canalicular membranes, as seen
in untreated cells, was almost completely abolished; in-
stead, actin had redistributed along the lateral membranes
(Fig. 6 b). Moreover, when cells were treated for 4 h with
PMA, the lateral staining was no longer observed, and ac-
tin filaments were scattered throughout the cell (Fig. 6 c).
Treatment of HepG2 cells with 100 nM PMA for 60 min
also had a dramatic effect on the bile canaliculi per se, as
judged by the redistribution of the bile canalicular mark-
ers villin (not shown) and MAB442 (Fig. 7 b). The canalic-
ular membrane labeling completely disappeared, leaving
only some faint background labeling of the cells. To obtain
further support for this notion, we examined whether
PMA also induced the redistribution of integral canalicu-
lar membrane proteins. To this end, we stained control
and PMA-treated cells for P-glycoprotein, using the P-gly-
coprotein–specific monoclonal antibody C219. As we
found for the other canalicular markers, the bile canalicu-
lar-specific labeling observed in control cells was almost
completely abolished in cells treated with 100 nM PMA.
After 60 min, the total number of bile canaliculi had de-
creased by .80% (Fig. 8). After 4 h, z95% of the bile
canaliculi had disappeared (data not shown).
To exclude potential artifacts and to determine whether
the morphological effect of PMA was caused by a specific
activation of PKC, the effect of the PKC inhibitor BIM on
the structural rearrangements of actin filaments and the
bile canalicular markers upon PMA addition, was deter-
mined. In Fig. 7 it is shown that cells pretreated with BIM
did not display a redistribution of MAB442 after a subse-
quent PMA treatment (Fig. 7 c). Also in phase-contrast
images, or after actin and villin staining, it could be dem-
onstrated that the cells remained polarized upon a com-
bined PMA/BIM treatment, showing bile canaliculi that
could not be distinguished from those in untreated cells
Table I. Staurosporine Stimulates the Synthesis and Basolateral Transport of C6-NBD-SM and GlcCer
Percentage of total NBD lipid
Back-exchange medium Intracellular Total
GlcCer SM GlcCer SM GlcCer SM
Control 6.5 6 1.6 17.8 6 1.8 1.8 6 0.7 6.3 6 1.0 8.3 6 2.3 24.2 6 1.4
(% of total) (78%) (74%)
1 Staurosporine 9.2 6 0.8 24.2 6 5.4 2.4 6 0.8 8.5 6 2.8 11.3 6 1.5 31.6 6 4.1
(% of total) (79%) (74%)
Cells were preincubated with 100 nM staurosporine in HBSS at 37°C for 30 min. Cells were then cooled and, in the presence of staurosporine, labeled and incubated with 3 mM
C6-NBD–Cer as described in Materials and Methods. Subsequently the cells were incubated at 37°C for 60 min in back-exchange medium and, after washing, scraped from the
culture dish. The lipids were extracted from the back-exchange medium, and the cells and the NBD lipids were quantified as described in Materials and Methods. The percentage
of lipid transported to the plasma membrane is indicated in parentheses. Data represent mean values 6SEM (n 5 4).
Figure 3. The effect of staurosporine on the total cellular uptake
of C6-NBD–SM and -GlcCer. HepG2 cells were preincubated
with 100 nM staurosporine in HBSS at 378C for 30 min. Cells
were then cooled and, in the presence of staurosporine, labeled
and incubated with 3 mM C6-NBD–SM or -GlcCer at 48C, as de-
scribed in Materials and Methods. Cells were then washed and in-
cubated at 378C for the indicated time intervals. After the incuba-
tion, cells were washed with cold PBS, back exchanged, and
scraped from the culture dish. Lipids from the cells were ex-
tracted and NBD lipids were quantified as described. The data
are shown as the mean of three independent experiments 6SEM.
Open symbols represent internalization of C6-NBD–GlcCer in
control (s) and staurosporine-treated (,) cells. Closed symbols
reflect internalization of C6-NBD–SM in control (d) and stauro-
sporine-treated (.) cells.Zegers and Hoekstra PKC and PKA Regulate Apical Sphingolipid Transport 313
(data not shown). This suggests that the depolarization of
HepG2 cells that occurred upon PMA treatment is medi-
ated by activation of PKC. Finally, treatment of the cells
with BIM alone did not give rise to any microscopically
detectable perturbation of cellular morphology over a pe-
riod of 60 min (Fig. 7 d).
To determine the fate of the bile canalicular markers vil-
lin and MAB442 upon PMA-induced cell depolarization,
the levels of both proteins were determined after the vari-
ous treatments. As shown in Fig. 9, the levels of villin in
cells treated with either PMA, BIM, or a combination of
PMA and BIM, remained virtually unaltered. Identical re-
sults were obtained for the levels of the protein to which
MAB442 was raised (data not shown). Thus, these results
indicate that the bile canalicular proteins are neither ex-
pelled from the cell nor rapidly degraded but rather redis-
tributed intracellularly upon activation of PKC activity.
PKC-mediated Cell Depolarization Involves an 
Inhibition of Apical Sphingolipid Transport and Is 
Related to the Mechanism Responsible for
Cell Depolarization
As described above, we observed that at low concentra-
tions (5–20 nM), PMA inhibits apical lipid transport, while
higher concentrations (100 nM) cause a complete disap-
pearance of the apical domain. Because the apical markers
redistribute intracellularly during cell depolarization, it is
possible that tight junctions open during depolarization,
which could result in the observed redistribution. The inhi-
bition of apical lipid transport by low PMA concentrations
could therefore be the result of a partial opening of the
tight junctions, allowing the apical lipid to reach the baso-
lateral surface from where it might have been removed by
back exchange in the lipid transport assay. To examine
such a potential effect of PMA on the tight junctions, we
allowed the cells to accumulate C6-NBD–SM in the apical
domain by incubating them with this lipid at 378C for 30
min. Cells were then treated with increasing concentrations
of PMA or EDTA as a positive control. Subsequently the
cells were back exchanged at 48C to determine the per-
centage of bile canaliculi from which the lipid could be ex-
tracted. In a parallel experiment, the total number of bile
canaliculi was determined, by staining them with the P-gly-
coprotein specific antibody C219. As shown in Fig. 8, the
results of this experiment revealed that at low concentra-
tions of PMA (5–20 nM), the tight junctions remain closed
Figure 4. PKC activity inhib-
its apical transport of sphin-
golipids. A shows the effect
of activator (PMA) or inhibi-
tor (BIM) of PKC activity on
direct transport of sphin-
golipids. In the presence of
PMA and/or BIM, cells were
labeled with 3 mM C6-NBD–
Cer at 48C, as described in
Materials and Methods. Cells
were then incubated at 378C
for 60 min in back-exchange
medium, while PMA and/or
BIM remained in the solu-
tion. Subsequently, cells
were washed and apical
transport was determined as
described in Materials and
Methods.  B shows the inhibi-
tion of transcytosis of C6-
NBD–SM and -GlcCer by PKC activity. Cells were incubated with 3 mM C6-NBD–GlcCer (white bars) or -SM (black bars) at 48C in the
presence of PMA and/or BIM. After a 15-min incubation at 378C in the presence of PMA and/or BIM, the cells were washed, cooled,
and back exchanged. Apical transport was determined as described in Materials and Methods. Note that in all experiments, the inhibi-
tor BIM (100 nM) was preincubated with the cells at 378C for 30 min.
Figure 5. Villin is specifically located in bile canaliculi in HepG2
cells. HepG2 cells were fixed and stained for villin using a mono-
clonal antibody. Note the specific location of villin in the bile
canalicular microvilli. Bar, 10 mm.The Journal of Cell Biology, Volume 138, 1997 314
and that depolarization of the cells does not occur. Only
after raising the PMA concentration up to 100 nM, apically
located lipid becomes accesible for back exchange to a level
that was also accomplished after treatment of the cells
with EDTA. Hence, opening of the tight junctions closely
correlates with the ultimate depolarization of the cells. We
conclude therefore that the reduced labeling of bile cana-
liculi at low PMA concentration, shown in Fig. 4, is indeed
due to PKC-regulated sphingolipid transport. In addition
to a decrease in apically directed sphingolipid transport, at
higher PMA concentrations, opening of the tight junctions
further participates in a dissipation of the apical domain,
including the labeled sphingolipids.
cAMP Stimulates Apical Sphingolipid Transport
As demonstrated above (Fig. 2), the kinase inhibitor stau-
rosporine inhibited transport of de novo synthesized sphin-
golipids in HepG2 cells. This result suggests that a kinase
other than PKC is positively regulating the direct lipid
transport route. Indeed, several investigators have re-
ported a stimulation of apical vesicular transport in both
MDCK cells and hepatocytes by cAMP (6, 9, 12, 32), sug-
gesting an involvement of protein kinase A (PKA) activity
in this process (32). These results prompted us to investi-
gate the role of cAMP on apical sphingolipid transport.
We therefore modulated the intracellular levels of cAMP
by using dibutyrylcAMP (dBcAMP) or forskolin, an acti-
vator of adenylate cyclase. In the latter case, IBMX, an in-
hibitor of phosphodiesterase, was included in some experi-
ments to prevent degradation of the newly synthesized
cAMP.
As demonstrated in Fig. 10, elevation of intracellular
cAMP stimulates apical sphingolipid transport both via
Figure 6. PMA causes a reorganization of actin filaments and de-
polarization of HepG2 cells. Cells were washed and incubated with
0.1% DMSO (control; a), or 100 nM PMA in HBSS at 378C for 60
min (b) and 4 h (c). Cells were then fixed and stained for actin us-
ing TRITC-labeled phalloidin, as described. Note that actin fila-
ments, located around bile canaliculi in control cells (a), redistrib-
ute upon PMA treatment (b and c). Bars, 10 mm.Zegers and Hoekstra PKC and PKA Regulate Apical Sphingolipid Transport 315
the direct route (Fig. 10 A) and via transcytosis (Fig. 10 B).
The stimulation of transcytotic lipid delivery did not result
from a dBcAMP-induced enhancement in cellular uptake
of exogenously supplied sphingolipids (Fig. 11). Upon
treatment of the cells with 1 mM dBcAMP, a stimulation
of 42% was observed in the transport of newly synthesized
fluorescent GlcCer and SM from Golgi to apical mem-
brane, i.e., the direct route (Fig. 10 A). With 1 mM forskolin,
the stimulation was less. However, when the concentration
was raised to 50 mM while 1 mM IBMX was included, di-
rect apical sphingolipid transport was stimulated to a simi-
lar extent as observed upon treatment with dBcAMP. The
stimulation of the direct transport route was not due to an
increased synthesis of Golgi-derived sphingolipids, as dB-
cAMP did not have any effect on the de novo synthesis of
C6-NBD–SM and -GlcCer as such (data not shown). To in-
vestigate whether the effects of cAMP were mediated via
PKA, the effect of a specific PKA inhibitor, H89, was sub-
sequently examined. As shown in Fig. 10 A, this com-
pound drastically inhibits the direct transport pathway of
Figure 7. PKC activity causes the redistribution of a bile canalicular antigen. Cells were preincubated with 500 nM of the PKC inhibitor
BIM in HBSS at 378C for 30 min (c and d), followed by an incubation for 60 min in HBSS, containing 0.1% DMSO (control; a), 100 nM
PMA (b), 500 nM BIM (c), or both (d). Finally, the cells were fixed and stained with MAB442 as described in Materials and Methods.
Note that the bile canalicular antigen to which MAB442 is directed, redistributes upon PMA treatment, which is counter-acted by BIM.
Bars, 10 mm.The Journal of Cell Biology, Volume 138, 1997 316
sphingolipids, suggesting that PKA is indeed positively
regulating apical lipid transport. Control experiments
showed that H89 had no effect on the de novo synthesis of
C6-NBD–SM and -GlcCer (data not shown).
cAMP Stimulates HepG2 Polarization Via Activation of 
Protein Kinase A
As shown above, PKC-induced inhibition of apical sphin-
golipid transport was accompanied by changes in the mor-
phology of the cells and finally resulted in the disappear-
ance of the apical domain (Figs. 6 and 7). It was of interest
therefore, to investigate whether stimulation of apical sphin-
golipid transport (by cAMP) was analogously reflected by
morphological effects on the bile canaliculi in HepG2
cells. To test this, the distribution of actin was determined
in HepG2 cells that had been treated with dBcAMP or with
forskolin and IBMX. To specifically relate such changes to
PKA activation, actin distribution was also determined in
cells that had been preincubated with the PKA inhibitor
H89, before subsequent treatment with dBcAMP. As
shown in Fig. 12 and Table II, an increase in bile canalicu-
lar structures, both in number and size, was seen after
treatment of the cells with dBcAMP or forskolin/IBMX.
Preincubation of the cells with H89, before the addition of
dBcAMP, prevented the formation of the large bile canalic-
uli, seen in cells that had only been treated with dBcAMP
(Fig. 12 d). To quantify the total amount of bile canalicular
structures in untreated and dBcAMP-treated cells, the
cells were double stained with the nuclear stain Hoechst
33258 and TRITC-labeled phalloidin, as a measure for to-
tal cells and bile canaliculi, respectively. From Table II it
becomes apparent that after a 4-h treatment with dB-
cAMP, the amount of bile canaliculi per number of cells
increased dramatically, showing almost three times more
bile canalicular structures compared to the number of such
structures in untreated cells. Preincubation with H89 in-
hibited the dBcAMP effect, indicating that the increase of
the amount of bile canaliculi was mediated via PKA acti-
vation.
Discussion
In this report we provide evidence that protein kinases are
responsible for the generation of a polarized cell morphol-
ogy in HepG2 cells. The inhibition of apical sphingolipid
transport by PKC and stimulation of this transport by PKA
are entirely consistent with the depolarizing and hyperpo-
larizing effect, respectively, of both kinases. Although the
kinase-induced effects on lipid transport are not directly
causing the depolarization or hyperpolarization, changes
in both phenonema, as controlled by kinase activity, are
directly reflected by adjustment in vesicular lipid trans-
port, which is most likely an instrument in the biogenesis
Figure 8. Opening of tight junctions and depolarization of
HepG2 cells depends on the concentration of PMA. Cells were
labeled with 3 mM C6-NBD–SM at 48C, as described in Materials
and Methods. The cells were then washed and allowed to accu-
mulate the fluorescent lipid in the apical domain, as accom-
plished by an incubation in HBSS at 378C for 30 min. Cells were
then treated with increasing concentrations of PMA in HBSS at
378C for 30 min. As a positive control, tight junctions were
opened by treatment with 25 mM EDTA in HBSS without Ca21,
at 378C for 15 min. After the incubations, the cells were washed,
cooled, and back exchanged. Cells that were treated with EDTA
were back exchanged in back-exchange medium without Ca21.
The percentage of NBD-positive bile canaliculi was determined
(crosshatched bars). In a parallel experiment, the total number of
bile canaliculi was determined by staining the cells with the P-gly-
coprotein–specific antibody C219. The total number of bile cana-
liculi in PMA-treated cells, and cells that were treated with EDTA,
was expressed as a percentage of control values (grey bars). Data
represent the mean 6SEM of three independent experiments.
Figure 9. PMA treatment does not change levels of villin in depo-
larized cells. Cells were washed and incubated with 0.1% DMSO
(control; lane 1), 100 nM PMA (lane 2), 500 nM BIM (lane 3), or
both (lane 4) at 378C in HBSS for 4 h. Gel electrophoresis and
Western blotting using a monoclonal antibody against villin were
performed as described in Materials and Methods. Note that both
PKC modulators do not affect the levels of villin. Bars show
quantitation of the Western blot by laser densitometric scanning
and represent the mean of two independent experiments.Zegers and Hoekstra PKC and PKA Regulate Apical Sphingolipid Transport 317
and maintenance of bile canalicular structures in this hu-
man hepatoma cell line.
As measured by monitoring the transport of fluores-
cently labeled SM and GlcCer, sphingolipid transport to
the bile canalicular structures, located between adjacent cells,
involves two different transport routes: (a) a transcytotic
pathway of basolaterally located sphingolipids and (b) a
transcytotic-independent (i.e., ‘direct’) pathway of Golgi-
derived, de novo synthesized sphingolipids. Based on sev-
eral observations we conclude that there are no common
compartments through which gross lipid transport along
both pathways proceeds and that they can operate, at least
in part, independently. First, the fluorescence distribution
patterns obtained for either pathway are entirely different
Figure 10. PKA activity
stimulates apical transport
of sphingolipids. HepG2 cells
were preincubated with vari-
ous PKA modulators in
HBSS at 378C for 30 min.
The compounds were kept
present during further incu-
bations.  A shows the effect of
PKA activity on direct trans-
port. Cells were labeled with
3 mM C6-NBD–Cer at 48C, as
described in Materials and
Methods. After an incuba-
tion at 378C for 60 min in
back-exchange medium, the
cells were washed and apical
transport was determined as
described. Data represent
the mean 6SEM of three to
five independent experi-
ments of cells treated with
0.1% DMSO (control), 1 mM
forskolin (1 mM FSK), 50 mM
forskolin combined with 1 mM IBMX (50 mM FSK/IBMX), 1 mM dBcAMP (dBcAMP), or 10 mM H89 (H 89). B shows the stimulation
of transcytosis of exogeneously inserted C6-NBD–SM and -GlcCer by dBcAMP. Cells were labeled with 3 mM C6-NBD–GlcCer (white
bars) or -SM (black bars) at 48C. After warming at 378C for 15 min in HBSS, the cells were subsequently washed, cooled, and back ex-
changed. Apical transport was determined as described in Materials and Methods. Data represent the mean of three independent experi-
ments 6SEM.
Figure 11. The effect of
PMA, cAMP, and H89 on to-
tal cellular uptake of C6-
NBD–SM and -GlcCer.
HepG2 cells were preincu-
bated with 20 nM PMA, 1
mM dBcAMP, or 10 mM H89
in HBSS at 378C for 30 min.
Cells were then cooled and,
in the presence of the drugs,
labeled and incubated with 3
mM C6-NBD–SM or -GlcCer
at 48C. Subsequent incuba-
tions were carried out at
378C for the indicated time
intervals. After the incuba-
tion, the cells were washed
with cold PBS, back ex-
changed, and scraped from
the culture dish. Lipids were
extracted, and NBD lipids
were quantified as de-
scribed. Data points repre-
sent the mean of three inde-
pendent experiments 6SEM.
(A) Internalization of C6-NBD–GlcCer in control (s), PMA-treated (h), dBcAMP-treated (n), and H89-treated (,) cells. (B) Inter-
nalization of C6-NBD–SM in control (d), PMA-treated (j), dBcAMP-treated (m), and H89-treated (.) cells.The Journal of Cell Biology, Volume 138, 1997 318
(Fig. 1). Furthermore, irrespective of the presence of BSA,
no distinguishable differences were observed in the label-
ing pattern in the direct pathway. This observation implies
that over the timespan of the experiment, substantial in-
termixing of the apical pool of lipids and that of lipids ini-
tially arriving basolaterally, does not occur. Second, the ki-
nase inhibitor staurosporine displayed differential effects
on both transport routes, causing a small stimulation of ba-
solateral-to-apical transcytosis of exogenously added sphin-
golipids but a pronounced inhibition of the direct route,
again irrespective of the presence of BSA.
Both the direct apical delivery of sphingolipid and the
transcytotic sphingolipid transport pathway are regulated
by kinase activity. The results presented show that activa-
Figure 12. cAMP induces a PKA-dependent increase in number of and enlargement of bile canaliculi. HepG2 cells were incubated for 4 h
at 378C in HBSS (a) supplemented with either 1 mM dBcAMP (b), 50 mM forskolin and 1 mM IBMX (c), or 1 mM dBcAMP and 10 mM
H89 (d). In the latter case cells had been preincubated with 10 mM H89 in HBSS at 378C for 30 min before the addition of dBcAMP. Af-
ter the incubation the cells were washed, fixed in ethanol, and bile canaliculi stained, using the actin stain TRITC–phalloidin, as de-
scribed in Materials and Methods. Note the enlargement of bile canaliculi, when compared to control cells (a), in cells that have been
treated with agents that induce an increase in intracellular cAMP concentration (b and c) but not in cells that were treated with both dB-
cAMP and the PKA inhibitor H89 (d). Bars, 10 mm.Zegers and Hoekstra PKC and PKA Regulate Apical Sphingolipid Transport 319
tion of PKC activity by PMA results in an inhibition of
apical sphingolipid transport while activation of PKA by
dBcAMP stimulates sphingolipid transport to the apical
domain. The inhibiting effect of PMA on apical sphingo-
lipid transport was eliminated by simultaneous addition of
BIM, a specific inhibitor of PKC activity, while BIM itself
stimulated transport. Likewise, H89, a specific inhibitor of
PKA activity, opposed the effects of dBcAMP and inhib-
ited apical sphingolipid transport.
To the best of our knowledge, this is the first demonstra-
tion that stimulation or inhibition of apically directed trans-
port is actually reflected by morphological alterations of
cell polarity. Thus, the morphological changes of the api-
cal domain, induced by PKC and PKA activation were
consistent with the lipid transport data. When PKC was
activated, the cells rapidly acquired a nonpolarized mor-
phology, as judged by the redistribution of four apical pro-
tein markers. Concomitantly, lipid transport via either
pathway decreased (Fig. 4). When the cells were exposed
to an elevated concentration of intracellular cAMP, a PKA-
dependent ‘hyperpolarization’ of HepG2 cells was in-
duced. Both direct apical and transcytotic lipid transport
routes were enhanced (Fig. 7), and the total amount of bile
canaliculi was increased threefold (Table II).
Effects of PKC agonists on apical transport of proteins
have been described before. In MDCK cells, phorbol es-
ters were reported to stimulate basolateral-to-apical trans-
cytosis of the polymeric immunoglobulin receptor (13) as
well as the direct transport of influenza hemagglutinin from
the TGN to the apical surface (32). However, it has also
been shown that after stimulation of PKC, bile secretion in
perfused rat liver (15) and vesicular transport to the apical
domain in rat hepatocytes (6) were inhibited. Our obser-
vations (Fig. 4) demonstrating that both the direct path-
way and transcytosis of fluorescently tagged SM and GlcCer
are inhibited, are entirely consistent with these studies.
Clearly, PKC interferes with an intracellular transport step
as both biosynthesis (‘direct pathway’; Table I), a prereq-
uisite for transport to occur, and internalization (transcy-
tosis) are affected in a manner that, consequently, would
lead to a diminished transport. Hence, recruitment of api-
cally destined sphingolipids from an intracellular pool is
impeded upon activation of PKC.
Interestingly, activation of PKC inhibits the internaliza-
tion of caveolea (39). In cells that do not possess caveolea,
the internalization of clustered GPI-linked proteins and the
glycosphingolipid GM1 is also inhibited upon activation of
PKC. It was shown that this PKC-induced inhibition of in-
ternalization was dependent on the actin cytoskeleton
(16). At present, the initial target of PKC, responsible for
the ultimate depolarization of HepG2 cells, is unknown.
However, along the lines of the foregoing discussion, a
possible explanation for the inhibitory effect of PKC on
apical lipid transport that we describe here, could be that
PKC directly influences transport from the TGN (direct
pathway) or from a sorting compartment in the transcy-
totic pathway (2, 4, 35). Thus, in HepG2 cells, PKC activity
could interfere with vesicular budding from these compart-
ments, analogous to its interference with budding in cave-
olae internalization or that of GPI/sphingolipid-enriched
microdomains (16, 39). Alternatively, PKC activation might
impede subsequent vesicular sphingolipid transport as a
result of the reorganization of the (apical) actin cytoskele-
ton and PKC-induced actin filament rearrangements, pre-
vent docking of vesicles. As hypothesized by Mays et al.
(28), actin could be critical for the final delivery of vesicles
at the apical surface, requiring an actin-based motor pro-
tein to traverse the apical terminal web and to dock even-
tually with the apical membrane. Indeed, as shown in Fig.
6, PKC activation caused a very rapid redistribution of ac-
tin filaments, and unpublished results indicate that apical
transport of sphingolipids is inhibited when actin filaments
are disrupted by cytochalasin D (Zegers, M.M.P., and D.
Hoekstra, manuscript in preparation). Nevertheless, fur-
ther work will be needed to determine whether the inhibi-
tion of apical lipid transport upon PKC activation arises
from secondary effects of actin rearrangements, or from a
direct effect of PKC activity on vesicular transport.
At present, the upstream effector of PKC responsible
for cell depolarization is unknown. Generally, cell–cell
contacts are important in the establishment of cell polar-
ity. The cell adhesion molecule E-cadherin was reported
to be required for the formation of extended bile canalicu-
lar membranes in hepatocytes (41). In this respect it is rel-
evant to note that in HT29 cells, PMA downmodulates to-
tal cellular levels of E-cadherin (18), which is accompanied
by a loss of the apical differentiation markers villin and
dipeptidylpeptidase IV (19). We submit that these re-
ported effects of PMA are likely related to the redistribu-
tion of the apical markers as we describe in this paper,
although we have found no evidence supporting a down-
regulation of protein levels.
The effects of cAMP on cell polarization reported here
may also be related to cell–cell contact-mediated signal-
ing. Experimental conditions that abolish cell–cell con-
tacts in MDCK cells trigger the formation of intracellular
microvilli-lined storage compartments for apical membrane
proteins, the vacuolar apical compartments (VACs; 47).
They are believed to arise through fusion of Golgi-derived
vesicles carrying newly synthesized proteins and lipids.
VACs are rapidly exocytosed upon restoration of cell–cell
contacts, and it has been suggested that this mechanism
plays an important role in the establishment of epithelial
cell polarity (48). Interestingly, the exocytosis of VACs
correlated with variations of cellular cAMP concentra-
Table II. dBcAMP Stimulates Formation of Bile canaliculi
via PKA
Ratio of bile canaliculi
to total cells
Control  1: 10.7 6 0.5
dBcAMP  1: 3.6 6 0.4
H89  1: 10.2 6 1.2
dBcAMP 1 H89 1: 7.2 6 1
HepG2 cells were washed and incubated with 1 mM dBcAMP, 10 mM H89, or both in
HBSS for 4 h at 37°C. When cells were incubated with both H89 and dBcAMP, the
cells were preincubated with H89 for 30 min in HBSS, before the addition of dB-
cAMP. After the incubation, cells were washed and double stained for actin and nu-
clei, using TRITC–phalloidin and Hoechst 33258, respectively, as described in Mate-
rials and Methods. Cells were examined by fluorescence microscopy. For each
condition, five random fields were scored for the total number of cells by counting nu-
clei, and the total number of bile canaliculi, stained with actin. Each field contained
200–300 cells. Data represent the mean 6SEM of four (control) or three (other condi-
tions) individual experiments.The Journal of Cell Biology, Volume 138, 1997 320
tions in response to cell–cell contacts. In the absence of
cell–cell contacts, the exocytosis of VACs could be in-
duced by the addition of cAMP (11). Moreover, cAMP was
reported to increase the amount of canalicular vacuoles,
found in single hepatocytes that no longer maintain a
polarized apical surface membrane (33). The above-
described results are entirely consistent with the effects of
cAMP presented here, involving a strong stimulation of
apically directed lipid transport and a drastic increase in
number and size of bile canalicular structures. The fact that
cAMP or cAMP analogues were also reported to stimulate
(vesicular) apical transport processes in epithelial cells (12,
17, 32) as well as in hepatocytes (6, 9, 21) suggests that this
second messenger has a general function in the generation
of cell polarity. The dBcAMP-induced stimulation of api-
cal vesicle targeting in hepatocyte couplets is counter-
acted by activation of PKC by phorbol ester (6), which is
also in accordance with our results that indicate that PKA
and PKC play opposing roles in apical lipid transport.
In conclusion, we have shown, for the first time, that ki-
nase activity regulates apical lipid transport. The evidence
indicates that PKC activity causes inhibition and PKA ac-
tivation of the transport of two sphingolipids, GlcCer and
SM, proceeding via the transcytotic and biosynthetic path-
ways. Moreover, morphological evidence demonstrates
that apical lipid transport is closely related to the organiza-
tion of the apical membrane, and thereby to the degree of
cell polarity. The role of cell–cell contact-mediated signal-
ing and the molecular targets of the various kinase activi-
ties as modulators of intracellular membrane flow, as re-
flected by lipid transport, are topics of current research in
our laboratory.
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